We recently hosted another live webinar for our Gold Partners, Mundipharma, this time asking the question, "Is high-risk BCR actually metastatic prostate cancer??". It's a reasonable question! This podcast was anchored from the GU Cast studio in Melbourne by usual hosts, Renu Eapen and Declan Murphy, joined in person by Andrew Loblaw, radiation oncologist from Toronto, and online by medical oncologist Jeff Goh in Brisbane.

What are we to make of this large RCT of extended vs standard pelvic lymph node dissection (PLND) for prostate cancer?? We chat with Dr Karim Touijer (MSKCC) and try to figure it out.